In tandem with its $100 million IPO, the biopharma-focused SPAC said it has an agreement with sponsor Jiya Holding Company for the sponsor to buy 500,000 shares of Class A common stock at $10 per share, resulting in proceeds of $5 million. Read more.
Jiya Discloses $5M Private Placement
